nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—ABCB1—colon cancer	0.492	1	CbGaD
Alitretinoin—CRABP1—embryo—colon cancer	0.00549	0.0893	CbGeAlD
Alitretinoin—CRABP2—embryo—colon cancer	0.00497	0.0807	CbGeAlD
Alitretinoin—CYP1A2—Fluorouracil—colon cancer	0.00395	0.313	CbGbCtD
Alitretinoin—CRABP2—smooth muscle tissue—colon cancer	0.0039	0.0635	CbGeAlD
Alitretinoin—RXRA—renal system—colon cancer	0.00374	0.0608	CbGeAlD
Alitretinoin—ABCB1—Irinotecan—colon cancer	0.0036	0.286	CbGbCtD
Alitretinoin—ABCB1—Vincristine—colon cancer	0.00315	0.25	CbGbCtD
Alitretinoin—CRABP2—digestive system—colon cancer	0.00308	0.0501	CbGeAlD
Alitretinoin—CRABP1—vagina—colon cancer	0.00301	0.0489	CbGeAlD
Alitretinoin—CRABP2—vagina—colon cancer	0.00272	0.0443	CbGeAlD
Alitretinoin—RARA—renal system—colon cancer	0.00258	0.0419	CbGeAlD
Alitretinoin—RARB—vagina—colon cancer	0.00243	0.0396	CbGeAlD
Alitretinoin—RXRA—liver—colon cancer	0.00229	0.0372	CbGeAlD
Alitretinoin—RARG—digestive system—colon cancer	0.00225	0.0366	CbGeAlD
Alitretinoin—RXRB—vagina—colon cancer	0.00224	0.0364	CbGeAlD
Alitretinoin—RARA—lymphoid tissue—colon cancer	0.00214	0.0348	CbGeAlD
Alitretinoin—RARB—liver—colon cancer	0.00205	0.0334	CbGeAlD
Alitretinoin—RARG—vagina—colon cancer	0.00199	0.0323	CbGeAlD
Alitretinoin—RARA—bone marrow—colon cancer	0.00195	0.0317	CbGeAlD
Alitretinoin—ABCB1—Methotrexate—colon cancer	0.0019	0.151	CbGbCtD
Alitretinoin—RXRB—liver—colon cancer	0.00189	0.0307	CbGeAlD
Alitretinoin—RARA—liver—colon cancer	0.00158	0.0256	CbGeAlD
Alitretinoin—RARB—lymph node—colon cancer	0.00157	0.0256	CbGeAlD
Alitretinoin—RARG—lymph node—colon cancer	0.00128	0.0209	CbGeAlD
Alitretinoin—RARA—lymph node—colon cancer	0.00121	0.0196	CbGeAlD
Alitretinoin—ABCB1—blood vessel—colon cancer	0.00108	0.0176	CbGeAlD
Alitretinoin—CYP1A2—renal system—colon cancer	0.000956	0.0155	CbGeAlD
Alitretinoin—CYP1A2—digestive system—colon cancer	0.000784	0.0127	CbGeAlD
Alitretinoin—ABCB1—embryo—colon cancer	0.000647	0.0105	CbGeAlD
Alitretinoin—CYP1A2—liver—colon cancer	0.000584	0.0095	CbGeAlD
Alitretinoin—ABCB1—epithelium—colon cancer	0.000528	0.00858	CbGeAlD
Alitretinoin—ABCB1—renal system—colon cancer	0.00049	0.00796	CbGeAlD
Alitretinoin—RARG—Generic Transcription Pathway—HNF4A—colon cancer	0.000411	0.0027	CbGpPWpGaD
Alitretinoin—ABCB1—lymphoid tissue—colon cancer	0.000407	0.00661	CbGeAlD
Alitretinoin—ABCB1—digestive system—colon cancer	0.000402	0.00653	CbGeAlD
Alitretinoin—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—colon cancer	0.000391	0.00257	CbGpPWpGaD
Alitretinoin—RXRB—a6b1 and a6b4 Integrin signaling—AKT1—colon cancer	0.000388	0.00255	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—HNF4A—colon cancer	0.000376	0.00247	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.00037	0.00244	CbGpPWpGaD
Alitretinoin—ABCB1—bone marrow—colon cancer	0.00037	0.00602	CbGeAlD
Alitretinoin—RARB—Generic Transcription Pathway—HNF4A—colon cancer	0.000368	0.00242	CbGpPWpGaD
Alitretinoin—CRABP1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	0.000365	0.0024	CbGpPWpGaD
Alitretinoin—CRABP2—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	0.000365	0.0024	CbGpPWpGaD
Alitretinoin—ABCB1—vagina—colon cancer	0.000355	0.00577	CbGeAlD
Alitretinoin—RXRB—Generic Transcription Pathway—HNF4A—colon cancer	0.000353	0.00232	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—HNF4A—colon cancer	0.000353	0.00232	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—HNF4A—colon cancer	0.000346	0.00228	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.000334	0.0022	CbGpPWpGaD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—PPARG—colon cancer	0.000333	0.00219	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.00032	0.0021	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—CTNNB1—colon cancer	0.000314	0.00207	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—CDKN1A—colon cancer	0.000307	0.00202	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—CHST5—colon cancer	0.000299	0.00197	CbGpPWpGaD
Alitretinoin—ABCB1—liver—colon cancer	0.000299	0.00487	CbGeAlD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.000296	0.00195	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—CTNNB1—colon cancer	0.000296	0.00195	CbGpPWpGaD
Alitretinoin—RXRA—Regulation of Androgen receptor activity—EP300—colon cancer	0.000293	0.00193	CbGpPWpGaD
Alitretinoin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000293	0.00193	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—CDKN1A—colon cancer	0.000289	0.0019	CbGpPWpGaD
Alitretinoin—RXRA—Regulation of Androgen receptor activity—SRC—colon cancer	0.000285	0.00188	CbGpPWpGaD
Alitretinoin—RXRA—a6b1 and a6b4 Integrin signaling—EGFR—colon cancer	0.000285	0.00188	CbGpPWpGaD
Alitretinoin—RXRA—Circadian Clock—EP300—colon cancer	0.000285	0.00188	CbGpPWpGaD
Alitretinoin—RXRA—Retinoic acid receptors-mediated signaling—AKT1—colon cancer	0.00028	0.00184	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CA7—colon cancer	0.000269	0.00177	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.000258	0.0017	CbGpPWpGaD
Alitretinoin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000256	0.00168	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—TGFB1—colon cancer	0.000254	0.00167	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.000253	0.00167	CbGpPWpGaD
Alitretinoin—Anaphylactic shock—Irinotecan—colon cancer	0.000252	0.000895	CcSEcCtD
Alitretinoin—Oedema—Irinotecan—colon cancer	0.000252	0.000895	CcSEcCtD
Alitretinoin—Myalgia—Fluorouracil—colon cancer	0.000252	0.000894	CcSEcCtD
Alitretinoin—Chest pain—Fluorouracil—colon cancer	0.000252	0.000894	CcSEcCtD
Alitretinoin—Infection—Irinotecan—colon cancer	0.000251	0.000889	CcSEcCtD
Alitretinoin—Hyperhidrosis—Vincristine—colon cancer	0.00025	0.000889	CcSEcCtD
Alitretinoin—RXRA—PPARA activates gene expression—PPARG—colon cancer	0.00025	0.00165	CbGpPWpGaD
Alitretinoin—Epistaxis—Capecitabine—colon cancer	0.00025	0.000886	CcSEcCtD
Alitretinoin—Discomfort—Fluorouracil—colon cancer	0.000249	0.000884	CcSEcCtD
Alitretinoin—Shock—Irinotecan—colon cancer	0.000248	0.000881	CcSEcCtD
Alitretinoin—RXRA—a6b1 and a6b4 Integrin signaling—PIK3CA—colon cancer	0.000247	0.00163	CbGpPWpGaD
Alitretinoin—Nervous system disorder—Irinotecan—colon cancer	0.000247	0.000878	CcSEcCtD
Alitretinoin—Agranulocytosis—Capecitabine—colon cancer	0.000247	0.000877	CcSEcCtD
Alitretinoin—Thrombocytopenia—Irinotecan—colon cancer	0.000247	0.000876	CcSEcCtD
Alitretinoin—Anorexia—Vincristine—colon cancer	0.000247	0.000876	CcSEcCtD
Alitretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—colon cancer	0.000245	0.00161	CbGpPWpGaD
Alitretinoin—Irritability—Methotrexate—colon cancer	0.000244	0.000866	CcSEcCtD
Alitretinoin—Hyperhidrosis—Irinotecan—colon cancer	0.000244	0.000865	CcSEcCtD
Alitretinoin—Confusional state—Fluorouracil—colon cancer	0.000244	0.000864	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.000243	0.0016	CbGpPWpGaD
Alitretinoin—Mood swings—Methotrexate—colon cancer	0.000242	0.00086	CcSEcCtD
Alitretinoin—Hypotension—Vincristine—colon cancer	0.000242	0.000859	CcSEcCtD
Alitretinoin—Oedema—Fluorouracil—colon cancer	0.000242	0.000857	CcSEcCtD
Alitretinoin—Anaphylactic shock—Fluorouracil—colon cancer	0.000242	0.000857	CcSEcCtD
Alitretinoin—Anorexia—Irinotecan—colon cancer	0.00024	0.000853	CcSEcCtD
Alitretinoin—Infection—Fluorouracil—colon cancer	0.00024	0.000852	CcSEcCtD
Alitretinoin—Haemoglobin—Capecitabine—colon cancer	0.000239	0.000847	CcSEcCtD
Alitretinoin—RARA—Adipogenesis—TGFB1—colon cancer	0.000239	0.00157	CbGpPWpGaD
Alitretinoin—Hepatitis—Capecitabine—colon cancer	0.000238	0.000843	CcSEcCtD
Alitretinoin—Haemorrhage—Capecitabine—colon cancer	0.000238	0.000843	CcSEcCtD
Alitretinoin—Nervous system disorder—Fluorouracil—colon cancer	0.000237	0.000841	CcSEcCtD
Alitretinoin—Thrombocytopenia—Fluorouracil—colon cancer	0.000237	0.000839	CcSEcCtD
Alitretinoin—Hypoaesthesia—Capecitabine—colon cancer	0.000236	0.000839	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Vincristine—colon cancer	0.000236	0.000837	CcSEcCtD
Alitretinoin—Pharyngitis—Capecitabine—colon cancer	0.000236	0.000837	CcSEcCtD
Alitretinoin—Tachycardia—Fluorouracil—colon cancer	0.000236	0.000837	CcSEcCtD
Alitretinoin—Hypotension—Irinotecan—colon cancer	0.000236	0.000836	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.000235	0.00155	CbGpPWpGaD
Alitretinoin—Urinary tract disorder—Capecitabine—colon cancer	0.000235	0.000833	CcSEcCtD
Alitretinoin—Insomnia—Vincristine—colon cancer	0.000234	0.000831	CcSEcCtD
Alitretinoin—Oedema peripheral—Capecitabine—colon cancer	0.000234	0.000831	CcSEcCtD
Alitretinoin—Urethral disorder—Capecitabine—colon cancer	0.000233	0.000827	CcSEcCtD
Alitretinoin—Paraesthesia—Vincristine—colon cancer	0.000233	0.000825	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.000231	0.00152	CbGpPWpGaD
Alitretinoin—Anorexia—Fluorouracil—colon cancer	0.00023	0.000817	CcSEcCtD
Alitretinoin—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.00023	0.000817	CcSEcCtD
Alitretinoin—ABCB1—lymph node—colon cancer	0.000229	0.00373	CbGeAlD
Alitretinoin—Visual impairment—Capecitabine—colon cancer	0.000229	0.000813	CcSEcCtD
Alitretinoin—RXRA—a6b1 and a6b4 Integrin signaling—HRAS—colon cancer	0.000229	0.00151	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.000229	0.00151	CbGpPWpGaD
Alitretinoin—Insomnia—Irinotecan—colon cancer	0.000228	0.00081	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.000227	0.00149	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.000227	0.00149	CbGpPWpGaD
Alitretinoin—Paraesthesia—Irinotecan—colon cancer	0.000227	0.000804	CcSEcCtD
Alitretinoin—Hypotension—Fluorouracil—colon cancer	0.000226	0.000801	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.000225	0.00148	CbGpPWpGaD
Alitretinoin—Decreased appetite—Vincristine—colon cancer	0.000225	0.000799	CcSEcCtD
Alitretinoin—Dyspnoea—Irinotecan—colon cancer	0.000225	0.000798	CcSEcCtD
Alitretinoin—Erythema multiforme—Capecitabine—colon cancer	0.000225	0.000797	CcSEcCtD
Alitretinoin—Somnolence—Irinotecan—colon cancer	0.000224	0.000796	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Vincristine—colon cancer	0.000224	0.000793	CcSEcCtD
Alitretinoin—Fatigue—Vincristine—colon cancer	0.000223	0.000792	CcSEcCtD
Alitretinoin—Eye disorder—Capecitabine—colon cancer	0.000222	0.000788	CcSEcCtD
Alitretinoin—Dyspepsia—Irinotecan—colon cancer	0.000222	0.000788	CcSEcCtD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	0.000222	0.00146	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	0.000222	0.00146	CbGpPWpGaD
Alitretinoin—Tinnitus—Capecitabine—colon cancer	0.000222	0.000786	CcSEcCtD
Alitretinoin—Constipation—Vincristine—colon cancer	0.000222	0.000786	CcSEcCtD
Alitretinoin—Pain—Vincristine—colon cancer	0.000222	0.000786	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.000221	0.00146	CbGpPWpGaD
Alitretinoin—Asthma—Methotrexate—colon cancer	0.000221	0.000784	CcSEcCtD
Alitretinoin—Flushing—Capecitabine—colon cancer	0.000221	0.000783	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00022	0.000781	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.000219	0.00144	CbGpPWpGaD
Alitretinoin—Decreased appetite—Irinotecan—colon cancer	0.000219	0.000778	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—PPARG—colon cancer	0.000219	0.00144	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.000219	0.00144	CbGpPWpGaD
Alitretinoin—Insomnia—Fluorouracil—colon cancer	0.000219	0.000775	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—colon cancer	0.000218	0.00143	CbGpPWpGaD
Alitretinoin—Gastrointestinal disorder—Irinotecan—colon cancer	0.000218	0.000773	CcSEcCtD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—EP300—colon cancer	0.000218	0.00143	CbGpPWpGaD
Alitretinoin—Fatigue—Irinotecan—colon cancer	0.000218	0.000772	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.000217	0.00143	CbGpPWpGaD
Alitretinoin—Paraesthesia—Fluorouracil—colon cancer	0.000217	0.00077	CcSEcCtD
Alitretinoin—Pancreatitis—Methotrexate—colon cancer	0.000217	0.000769	CcSEcCtD
Alitretinoin—Pain—Irinotecan—colon cancer	0.000216	0.000765	CcSEcCtD
Alitretinoin—Constipation—Irinotecan—colon cancer	0.000216	0.000765	CcSEcCtD
Alitretinoin—Angiopathy—Capecitabine—colon cancer	0.000216	0.000765	CcSEcCtD
Alitretinoin—Dyspnoea—Fluorouracil—colon cancer	0.000215	0.000764	CcSEcCtD
Alitretinoin—Somnolence—Fluorouracil—colon cancer	0.000215	0.000762	CcSEcCtD
Alitretinoin—Chills—Capecitabine—colon cancer	0.000213	0.000757	CcSEcCtD
Alitretinoin—Dyspepsia—Fluorouracil—colon cancer	0.000213	0.000755	CcSEcCtD
Alitretinoin—Arrhythmia—Capecitabine—colon cancer	0.000212	0.000753	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.000212	0.0014	CbGpPWpGaD
Alitretinoin—Abdominal discomfort—Methotrexate—colon cancer	0.000212	0.000752	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Vincristine—colon cancer	0.000212	0.000752	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.000211	0.00139	CbGpPWpGaD
Alitretinoin—Decreased appetite—Fluorouracil—colon cancer	0.00021	0.000745	CcSEcCtD
Alitretinoin—Alopecia—Capecitabine—colon cancer	0.00021	0.000745	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000209	0.00074	CcSEcCtD
Alitretinoin—Mental disorder—Capecitabine—colon cancer	0.000208	0.000739	CcSEcCtD
Alitretinoin—Feeling abnormal—Irinotecan—colon cancer	0.000208	0.000738	CcSEcCtD
Alitretinoin—Erythema—Capecitabine—colon cancer	0.000207	0.000734	CcSEcCtD
Alitretinoin—Malnutrition—Capecitabine—colon cancer	0.000207	0.000734	CcSEcCtD
Alitretinoin—Neutropenia—Methotrexate—colon cancer	0.000207	0.000733	CcSEcCtD
Alitretinoin—Dysuria—Methotrexate—colon cancer	0.000207	0.000733	CcSEcCtD
Alitretinoin—Pain—Fluorouracil—colon cancer	0.000207	0.000733	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Irinotecan—colon cancer	0.000206	0.000732	CcSEcCtD
Alitretinoin—RXRA—Developmental Biology—DCC—colon cancer	0.000206	0.00135	CbGpPWpGaD
Alitretinoin—Upper respiratory tract infection—Methotrexate—colon cancer	0.000205	0.000729	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.000205	0.00135	CbGpPWpGaD
Alitretinoin—Abdominal pain—Vincristine—colon cancer	0.000205	0.000727	CcSEcCtD
Alitretinoin—Body temperature increased—Vincristine—colon cancer	0.000205	0.000727	CcSEcCtD
Alitretinoin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000204	0.00134	CbGpPWpGaD
Alitretinoin—Flatulence—Capecitabine—colon cancer	0.000204	0.000723	CcSEcCtD
Alitretinoin—RXRA—a6b1 and a6b4 Integrin signaling—AKT1—colon cancer	0.000202	0.00133	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.000202	0.00133	CbGpPWpGaD
Alitretinoin—Photosensitivity reaction—Methotrexate—colon cancer	0.000202	0.000716	CcSEcCtD
Alitretinoin—Back pain—Capecitabine—colon cancer	0.0002	0.00071	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.000199	0.00131	CbGpPWpGaD
Alitretinoin—Body temperature increased—Irinotecan—colon cancer	0.000199	0.000708	CcSEcCtD
Alitretinoin—Abdominal pain—Irinotecan—colon cancer	0.000199	0.000708	CcSEcCtD
Alitretinoin—Feeling abnormal—Fluorouracil—colon cancer	0.000199	0.000706	CcSEcCtD
Alitretinoin—Pneumonia—Methotrexate—colon cancer	0.000198	0.000703	CcSEcCtD
Alitretinoin—RARG—Gene Expression—HNF4A—colon cancer	0.000198	0.0013	CbGpPWpGaD
Alitretinoin—Drowsiness—Methotrexate—colon cancer	0.000197	0.000699	CcSEcCtD
Alitretinoin—Infestation NOS—Methotrexate—colon cancer	0.000197	0.000699	CcSEcCtD
Alitretinoin—Infestation—Methotrexate—colon cancer	0.000197	0.000699	CcSEcCtD
Alitretinoin—Depression—Methotrexate—colon cancer	0.000197	0.000697	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.000196	0.00129	CbGpPWpGaD
Alitretinoin—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000195	0.000693	CcSEcCtD
Alitretinoin—Vision blurred—Capecitabine—colon cancer	0.000195	0.000692	CcSEcCtD
Alitretinoin—Tremor—Capecitabine—colon cancer	0.000194	0.000688	CcSEcCtD
Alitretinoin—Renal failure—Methotrexate—colon cancer	0.000194	0.000687	CcSEcCtD
Alitretinoin—Stomatitis—Methotrexate—colon cancer	0.000192	0.000682	CcSEcCtD
Alitretinoin—Ill-defined disorder—Capecitabine—colon cancer	0.000192	0.000681	CcSEcCtD
Alitretinoin—Urticaria—Fluorouracil—colon cancer	0.000192	0.000681	CcSEcCtD
Alitretinoin—Conjunctivitis—Methotrexate—colon cancer	0.000192	0.00068	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.000191	0.00126	CbGpPWpGaD
Alitretinoin—Anaemia—Capecitabine—colon cancer	0.000191	0.000678	CcSEcCtD
Alitretinoin—Body temperature increased—Fluorouracil—colon cancer	0.000191	0.000678	CcSEcCtD
Alitretinoin—Hypersensitivity—Vincristine—colon cancer	0.000191	0.000677	CcSEcCtD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—colon cancer	0.000189	0.00125	CbGpPWpGaD
Alitretinoin—Sweating—Methotrexate—colon cancer	0.000189	0.00067	CcSEcCtD
Alitretinoin—Haematuria—Methotrexate—colon cancer	0.000188	0.000667	CcSEcCtD
Alitretinoin—Malaise—Capecitabine—colon cancer	0.000187	0.000662	CcSEcCtD
Alitretinoin—Epistaxis—Methotrexate—colon cancer	0.000186	0.00066	CcSEcCtD
Alitretinoin—Hypersensitivity—Irinotecan—colon cancer	0.000186	0.000659	CcSEcCtD
Alitretinoin—Asthenia—Vincristine—colon cancer	0.000186	0.000659	CcSEcCtD
Alitretinoin—Syncope—Capecitabine—colon cancer	0.000186	0.000658	CcSEcCtD
Alitretinoin—RXRA—Generic Transcription Pathway—HNF4A—colon cancer	0.000184	0.00121	CbGpPWpGaD
Alitretinoin—Agranulocytosis—Methotrexate—colon cancer	0.000184	0.000653	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.000184	0.00121	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.000183	0.0012	CbGpPWpGaD
Alitretinoin—Palpitations—Capecitabine—colon cancer	0.000183	0.000649	CcSEcCtD
Alitretinoin—Loss of consciousness—Capecitabine—colon cancer	0.000182	0.000645	CcSEcCtD
Alitretinoin—Asthenia—Irinotecan—colon cancer	0.000181	0.000642	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—HNF4A—colon cancer	0.000181	0.00119	CbGpPWpGaD
Alitretinoin—Cough—Capecitabine—colon cancer	0.000181	0.000641	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.00018	0.00118	CbGpPWpGaD
Alitretinoin—Hypertension—Capecitabine—colon cancer	0.000179	0.000634	CcSEcCtD
Alitretinoin—RARG—Generic Transcription Pathway—PPARG—colon cancer	0.000178	0.00117	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Fluorouracil—colon cancer	0.000178	0.000632	CcSEcCtD
Alitretinoin—Haemoglobin—Methotrexate—colon cancer	0.000178	0.000631	CcSEcCtD
Alitretinoin—RARB—Gene Expression—HNF4A—colon cancer	0.000177	0.00117	CbGpPWpGaD
Alitretinoin—Diarrhoea—Vincristine—colon cancer	0.000177	0.000629	CcSEcCtD
Alitretinoin—Haemorrhage—Methotrexate—colon cancer	0.000177	0.000628	CcSEcCtD
Alitretinoin—Hepatitis—Methotrexate—colon cancer	0.000177	0.000628	CcSEcCtD
Alitretinoin—Myalgia—Capecitabine—colon cancer	0.000176	0.000625	CcSEcCtD
Alitretinoin—Chest pain—Capecitabine—colon cancer	0.000176	0.000625	CcSEcCtD
Alitretinoin—Arthralgia—Capecitabine—colon cancer	0.000176	0.000625	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.000176	0.00116	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.000176	0.00116	CbGpPWpGaD
Alitretinoin—Pharyngitis—Methotrexate—colon cancer	0.000176	0.000623	CcSEcCtD
Alitretinoin—Anxiety—Capecitabine—colon cancer	0.000176	0.000623	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.000176	0.00116	CbGpPWpGaD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000175	0.000621	CcSEcCtD
Alitretinoin—Urinary tract disorder—Methotrexate—colon cancer	0.000175	0.00062	CcSEcCtD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	0.000175	0.00115	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	0.000175	0.00115	CbGpPWpGaD
Alitretinoin—Discomfort—Capecitabine—colon cancer	0.000174	0.000617	CcSEcCtD
Alitretinoin—Urethral disorder—Methotrexate—colon cancer	0.000173	0.000615	CcSEcCtD
Alitretinoin—RXRA—Developmental Biology—HNF4A—colon cancer	0.000173	0.00114	CbGpPWpGaD
Alitretinoin—Diarrhoea—Irinotecan—colon cancer	0.000173	0.000612	CcSEcCtD
Alitretinoin—Dry mouth—Capecitabine—colon cancer	0.000172	0.000611	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.000172	0.00113	CbGpPWpGaD
Alitretinoin—Dizziness—Vincristine—colon cancer	0.000171	0.000608	CcSEcCtD
Alitretinoin—Pruritus—Fluorouracil—colon cancer	0.000171	0.000607	CcSEcCtD
Alitretinoin—Visual impairment—Methotrexate—colon cancer	0.000171	0.000605	CcSEcCtD
Alitretinoin—Confusional state—Capecitabine—colon cancer	0.00017	0.000604	CcSEcCtD
Alitretinoin—RARA—Gene Expression—HNF4A—colon cancer	0.00017	0.00112	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—HNF4A—colon cancer	0.00017	0.00112	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.00017	0.00112	CbGpPWpGaD
Alitretinoin—Oedema—Capecitabine—colon cancer	0.000169	0.000599	CcSEcCtD
Alitretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	0.000169	0.00111	CbGpPWpGaD
Alitretinoin—Infection—Capecitabine—colon cancer	0.000168	0.000595	CcSEcCtD
Alitretinoin—Erythema multiforme—Methotrexate—colon cancer	0.000167	0.000593	CcSEcCtD
Alitretinoin—Dizziness—Irinotecan—colon cancer	0.000167	0.000592	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.000167	0.0011	CbGpPWpGaD
Alitretinoin—Shock—Capecitabine—colon cancer	0.000166	0.000589	CcSEcCtD
Alitretinoin—Nervous system disorder—Capecitabine—colon cancer	0.000166	0.000587	CcSEcCtD
Alitretinoin—Eye disorder—Methotrexate—colon cancer	0.000165	0.000587	CcSEcCtD
Alitretinoin—Diarrhoea—Fluorouracil—colon cancer	0.000165	0.000587	CcSEcCtD
Alitretinoin—Thrombocytopenia—Capecitabine—colon cancer	0.000165	0.000587	CcSEcCtD
Alitretinoin—Tinnitus—Methotrexate—colon cancer	0.000165	0.000585	CcSEcCtD
Alitretinoin—Tachycardia—Capecitabine—colon cancer	0.000165	0.000585	CcSEcCtD
Alitretinoin—Vomiting—Vincristine—colon cancer	0.000165	0.000584	CcSEcCtD
Alitretinoin—Skin disorder—Capecitabine—colon cancer	0.000164	0.000582	CcSEcCtD
Alitretinoin—RXRA—PPARA activates gene expression—EP300—colon cancer	0.000164	0.00108	CbGpPWpGaD
Alitretinoin—Rash—Vincristine—colon cancer	0.000163	0.000579	CcSEcCtD
Alitretinoin—Hyperhidrosis—Capecitabine—colon cancer	0.000163	0.000579	CcSEcCtD
Alitretinoin—Dermatitis—Vincristine—colon cancer	0.000163	0.000579	CcSEcCtD
Alitretinoin—RXRG—Generic Transcription Pathway—PPARG—colon cancer	0.000163	0.00107	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CHST5—colon cancer	0.000163	0.00107	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ODC1—colon cancer	0.000163	0.00107	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.000163	0.00107	CbGpPWpGaD
Alitretinoin—Headache—Vincristine—colon cancer	0.000162	0.000576	CcSEcCtD
Alitretinoin—Anorexia—Capecitabine—colon cancer	0.000161	0.000571	CcSEcCtD
Alitretinoin—Angiopathy—Methotrexate—colon cancer	0.000161	0.00057	CcSEcCtD
Alitretinoin—Vomiting—Irinotecan—colon cancer	0.00016	0.000569	CcSEcCtD
Alitretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	0.00016	0.00105	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—PPARG—colon cancer	0.00016	0.00105	CbGpPWpGaD
Alitretinoin—Dizziness—Fluorouracil—colon cancer	0.00016	0.000567	CcSEcCtD
Alitretinoin—Rash—Irinotecan—colon cancer	0.000159	0.000564	CcSEcCtD
Alitretinoin—Dermatitis—Irinotecan—colon cancer	0.000159	0.000564	CcSEcCtD
Alitretinoin—Chills—Methotrexate—colon cancer	0.000159	0.000563	CcSEcCtD
Alitretinoin—Headache—Irinotecan—colon cancer	0.000158	0.000561	CcSEcCtD
Alitretinoin—Hypotension—Capecitabine—colon cancer	0.000158	0.00056	CcSEcCtD
Alitretinoin—Alopecia—Methotrexate—colon cancer	0.000156	0.000555	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000156	0.00103	CbGpPWpGaD
Alitretinoin—Mental disorder—Methotrexate—colon cancer	0.000155	0.00055	CcSEcCtD
Alitretinoin—Malnutrition—Methotrexate—colon cancer	0.000154	0.000546	CcSEcCtD
Alitretinoin—Erythema—Methotrexate—colon cancer	0.000154	0.000546	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—CTNNB1—colon cancer	0.000154	0.00101	CbGpPWpGaD
Alitretinoin—Nausea—Vincristine—colon cancer	0.000154	0.000546	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000154	0.000546	CcSEcCtD
Alitretinoin—Vomiting—Fluorouracil—colon cancer	0.000154	0.000545	CcSEcCtD
Alitretinoin—RARA—Generic Transcription Pathway—PPARG—colon cancer	0.000153	0.00101	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—PPARG—colon cancer	0.000153	0.00101	CbGpPWpGaD
Alitretinoin—Insomnia—Capecitabine—colon cancer	0.000153	0.000542	CcSEcCtD
Alitretinoin—Rash—Fluorouracil—colon cancer	0.000152	0.000541	CcSEcCtD
Alitretinoin—Dermatitis—Fluorouracil—colon cancer	0.000152	0.00054	CcSEcCtD
Alitretinoin—Paraesthesia—Capecitabine—colon cancer	0.000152	0.000538	CcSEcCtD
Alitretinoin—Headache—Fluorouracil—colon cancer	0.000151	0.000537	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.000151	0.000992	CbGpPWpGaD
Alitretinoin—Dyspnoea—Capecitabine—colon cancer	0.000151	0.000534	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—CDKN1A—colon cancer	0.00015	0.00099	CbGpPWpGaD
Alitretinoin—Nausea—Irinotecan—colon cancer	0.00015	0.000532	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000149	0.000983	CbGpPWpGaD
Alitretinoin—Back pain—Methotrexate—colon cancer	0.000149	0.000529	CcSEcCtD
Alitretinoin—Dyspepsia—Capecitabine—colon cancer	0.000149	0.000527	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.000148	0.000974	CbGpPWpGaD
Alitretinoin—Decreased appetite—Capecitabine—colon cancer	0.000147	0.000521	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Capecitabine—colon cancer	0.000146	0.000517	CcSEcCtD
Alitretinoin—Fatigue—Capecitabine—colon cancer	0.000146	0.000516	CcSEcCtD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—EP300—colon cancer	0.000145	0.000955	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—EP300—colon cancer	0.000145	0.000955	CbGpPWpGaD
Alitretinoin—Vision blurred—Methotrexate—colon cancer	0.000145	0.000515	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.000145	0.000951	CbGpPWpGaD
Alitretinoin—Pain—Capecitabine—colon cancer	0.000144	0.000512	CcSEcCtD
Alitretinoin—Constipation—Capecitabine—colon cancer	0.000144	0.000512	CcSEcCtD
Alitretinoin—Nausea—Fluorouracil—colon cancer	0.000144	0.000509	CcSEcCtD
Alitretinoin—Ill-defined disorder—Methotrexate—colon cancer	0.000143	0.000507	CcSEcCtD
Alitretinoin—Anaemia—Methotrexate—colon cancer	0.000142	0.000505	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—ABCB1—colon cancer	0.000142	0.000935	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—ABCB1—colon cancer	0.000142	0.000935	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—TYMS—colon cancer	0.000139	0.000918	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—TYMS—colon cancer	0.000139	0.000918	CbGpPWpGaD
Alitretinoin—Feeling abnormal—Capecitabine—colon cancer	0.000139	0.000494	CcSEcCtD
Alitretinoin—Malaise—Methotrexate—colon cancer	0.000139	0.000493	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Capecitabine—colon cancer	0.000138	0.00049	CcSEcCtD
Alitretinoin—Cough—Methotrexate—colon cancer	0.000134	0.000477	CcSEcCtD
Alitretinoin—Urticaria—Capecitabine—colon cancer	0.000134	0.000476	CcSEcCtD
Alitretinoin—Body temperature increased—Capecitabine—colon cancer	0.000133	0.000474	CcSEcCtD
Alitretinoin—Abdominal pain—Capecitabine—colon cancer	0.000133	0.000474	CcSEcCtD
Alitretinoin—Convulsion—Methotrexate—colon cancer	0.000133	0.000473	CcSEcCtD
Alitretinoin—Chest pain—Methotrexate—colon cancer	0.000131	0.000465	CcSEcCtD
Alitretinoin—Arthralgia—Methotrexate—colon cancer	0.000131	0.000465	CcSEcCtD
Alitretinoin—Myalgia—Methotrexate—colon cancer	0.000131	0.000465	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00013	0.000462	CcSEcCtD
Alitretinoin—Discomfort—Methotrexate—colon cancer	0.00013	0.00046	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000127	0.000838	CbGpPWpGaD
Alitretinoin—Confusional state—Methotrexate—colon cancer	0.000127	0.00045	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.000127	0.000833	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	0.000126	0.00083	CbGpPWpGaD
Alitretinoin—Anaphylactic shock—Methotrexate—colon cancer	0.000126	0.000446	CcSEcCtD
Alitretinoin—Infection—Methotrexate—colon cancer	0.000125	0.000443	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—TGFB1—colon cancer	0.000124	0.000819	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Capecitabine—colon cancer	0.000124	0.000441	CcSEcCtD
Alitretinoin—Nervous system disorder—Methotrexate—colon cancer	0.000123	0.000437	CcSEcCtD
Alitretinoin—Thrombocytopenia—Methotrexate—colon cancer	0.000123	0.000437	CcSEcCtD
Alitretinoin—Skin disorder—Methotrexate—colon cancer	0.000122	0.000433	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000122	0.000803	CbGpPWpGaD
Alitretinoin—Hyperhidrosis—Methotrexate—colon cancer	0.000122	0.000431	CcSEcCtD
Alitretinoin—Asthenia—Capecitabine—colon cancer	0.000121	0.00043	CcSEcCtD
Alitretinoin—Anorexia—Methotrexate—colon cancer	0.00012	0.000425	CcSEcCtD
Alitretinoin—Pruritus—Capecitabine—colon cancer	0.000119	0.000424	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.000118	0.000779	CbGpPWpGaD
Alitretinoin—CYP1A2—Arachidonic acid metabolism—PTGS2—colon cancer	0.000118	0.000776	CbGpPWpGaD
Alitretinoin—Hypotension—Methotrexate—colon cancer	0.000117	0.000417	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.000117	0.000773	CbGpPWpGaD
Alitretinoin—Diarrhoea—Capecitabine—colon cancer	0.000116	0.00041	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000115	0.000406	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.000114	0.000752	CbGpPWpGaD
Alitretinoin—Insomnia—Methotrexate—colon cancer	0.000114	0.000403	CcSEcCtD
Alitretinoin—RXRA—NRF2 pathway—TGFB1—colon cancer	0.000113	0.000746	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.000113	0.000745	CbGpPWpGaD
Alitretinoin—Paraesthesia—Methotrexate—colon cancer	0.000113	0.0004	CcSEcCtD
Alitretinoin—Dyspnoea—Methotrexate—colon cancer	0.000112	0.000398	CcSEcCtD
Alitretinoin—Somnolence—Methotrexate—colon cancer	0.000112	0.000396	CcSEcCtD
Alitretinoin—Dizziness—Capecitabine—colon cancer	0.000112	0.000396	CcSEcCtD
Alitretinoin—Dyspepsia—Methotrexate—colon cancer	0.000111	0.000393	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.000111	0.000728	CbGpPWpGaD
Alitretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	0.00011	0.000726	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	0.00011	0.000725	CbGpPWpGaD
Alitretinoin—Decreased appetite—Methotrexate—colon cancer	0.000109	0.000388	CcSEcCtD
Alitretinoin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	0.000109	0.000716	CbGpPWpGaD
Alitretinoin—Gastrointestinal disorder—Methotrexate—colon cancer	0.000109	0.000385	CcSEcCtD
Alitretinoin—Fatigue—Methotrexate—colon cancer	0.000108	0.000384	CcSEcCtD
Alitretinoin—Pain—Methotrexate—colon cancer	0.000107	0.000381	CcSEcCtD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	0.000107	0.000707	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	0.000107	0.000707	CbGpPWpGaD
Alitretinoin—Vomiting—Capecitabine—colon cancer	0.000107	0.000381	CcSEcCtD
Alitretinoin—ABCB1—Metabolism—CA7—colon cancer	0.000107	0.000706	CbGpPWpGaD
Alitretinoin—Rash—Capecitabine—colon cancer	0.000106	0.000378	CcSEcCtD
Alitretinoin—Dermatitis—Capecitabine—colon cancer	0.000106	0.000377	CcSEcCtD
Alitretinoin—Headache—Capecitabine—colon cancer	0.000106	0.000375	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.000105	0.000693	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	0.000105	0.00069	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—colon cancer	0.000105	0.00069	CbGpPWpGaD
Alitretinoin—Feeling abnormal—Methotrexate—colon cancer	0.000104	0.000367	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Methotrexate—colon cancer	0.000103	0.000365	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.000102	0.000673	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—colon cancer	0.000102	0.000671	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	0.000102	0.000671	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—MYC—colon cancer	0.000102	0.000669	CbGpPWpGaD
Alitretinoin—Nausea—Capecitabine—colon cancer	0.0001	0.000356	CcSEcCtD
Alitretinoin—Urticaria—Methotrexate—colon cancer	9.99e-05	0.000354	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	9.97e-05	0.000656	CbGpPWpGaD
Alitretinoin—Abdominal pain—Methotrexate—colon cancer	9.94e-05	0.000353	CcSEcCtD
Alitretinoin—Body temperature increased—Methotrexate—colon cancer	9.94e-05	0.000353	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	9.93e-05	0.000654	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PPARG—colon cancer	9.88e-05	0.00065	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PPARG—colon cancer	9.88e-05	0.00065	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	9.84e-05	0.000648	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—colon cancer	9.81e-05	0.000646	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CASP3—colon cancer	9.51e-05	0.000626	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	9.32e-05	0.000613	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—MYC—colon cancer	9.3e-05	0.000612	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Methotrexate—colon cancer	9.26e-05	0.000329	CcSEcCtD
Alitretinoin—RXRA—Transmembrane transport of small molecules—ABCB1—colon cancer	9.18e-05	0.000604	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	9.17e-05	0.000604	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	9.15e-05	0.000602	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—colon cancer	9.14e-05	0.000601	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—MYC—colon cancer	9.12e-05	0.0006	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	9.12e-05	0.0006	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	9.07e-05	0.000597	CbGpPWpGaD
Alitretinoin—Asthenia—Methotrexate—colon cancer	9.02e-05	0.00032	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	8.97e-05	0.00059	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	8.94e-05	0.000588	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	8.94e-05	0.000588	CbGpPWpGaD
Alitretinoin—Pruritus—Methotrexate—colon cancer	8.89e-05	0.000316	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—HNF4A—colon cancer	8.86e-05	0.000583	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	8.74e-05	0.000575	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—MYC—colon cancer	8.74e-05	0.000575	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—MYC—colon cancer	8.74e-05	0.000575	CbGpPWpGaD
Alitretinoin—Diarrhoea—Methotrexate—colon cancer	8.6e-05	0.000305	CcSEcCtD
Alitretinoin—RARG—Gene Expression—PPARG—colon cancer	8.58e-05	0.000565	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CA7—colon cancer	8.57e-05	0.000564	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	8.47e-05	0.000558	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	8.44e-05	0.000556	CbGpPWpGaD
Alitretinoin—Dizziness—Methotrexate—colon cancer	8.31e-05	0.000295	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—VEGFA—colon cancer	8.07e-05	0.000531	CbGpPWpGaD
Alitretinoin—Vomiting—Methotrexate—colon cancer	7.99e-05	0.000284	CcSEcCtD
Alitretinoin—RXRA—Generic Transcription Pathway—PPARG—colon cancer	7.99e-05	0.000526	CbGpPWpGaD
Alitretinoin—Rash—Methotrexate—colon cancer	7.93e-05	0.000281	CcSEcCtD
Alitretinoin—Dermatitis—Methotrexate—colon cancer	7.92e-05	0.000281	CcSEcCtD
Alitretinoin—Headache—Methotrexate—colon cancer	7.87e-05	0.000279	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—PPARG—colon cancer	7.85e-05	0.000517	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	7.78e-05	0.000512	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PTGS2—colon cancer	7.77e-05	0.000512	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PTGS2—colon cancer	7.77e-05	0.000512	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—PPARG—colon cancer	7.7e-05	0.000507	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	7.53e-05	0.000496	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—PPARG—colon cancer	7.52e-05	0.000495	CbGpPWpGaD
Alitretinoin—Nausea—Methotrexate—colon cancer	7.47e-05	0.000265	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—TGFB1—colon cancer	7.41e-05	0.000488	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—PPARG—colon cancer	7.38e-05	0.000486	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—PPARG—colon cancer	7.38e-05	0.000486	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	7.18e-05	0.000472	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARG—colon cancer	6.72e-05	0.000442	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	6.66e-05	0.000438	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CHST5—colon cancer	6.5e-05	0.000428	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ODC1—colon cancer	6.5e-05	0.000428	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—EP300—colon cancer	6.46e-05	0.000425	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—EP300—colon cancer	6.46e-05	0.000425	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	6.36e-05	0.000419	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	5.95e-05	0.000391	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—CTNNB1—colon cancer	5.29e-05	0.000348	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	5.28e-05	0.000348	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ODC1—colon cancer	5.19e-05	0.000342	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CHST5—colon cancer	5.19e-05	0.000342	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	5.06e-05	0.000333	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—EP300—colon cancer	4.92e-05	0.000324	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—MYC—colon cancer	4.89e-05	0.000322	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—SRC—colon cancer	4.78e-05	0.000315	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PIK3CA—colon cancer	4.78e-05	0.000315	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PIK3CA—colon cancer	4.78e-05	0.000315	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	4.69e-05	0.000309	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—VEGFA—colon cancer	4.66e-05	0.000307	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—NRAS—colon cancer	4.6e-05	0.000303	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	4.57e-05	0.000301	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—MYC—colon cancer	4.56e-05	0.0003	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	4.52e-05	0.000298	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—MYC—colon cancer	4.48e-05	0.000295	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	4.42e-05	0.000291	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.39e-05	0.000289	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—MYC—colon cancer	4.39e-05	0.000289	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ABCB1—colon cancer	4.3e-05	0.000283	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TGFB1—colon cancer	4.28e-05	0.000282	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—TYMS—colon cancer	4.22e-05	0.000278	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—MYC—colon cancer	4.21e-05	0.000277	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—MYC—colon cancer	4.21e-05	0.000277	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	4.21e-05	0.000277	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—EGFR—colon cancer	4.19e-05	0.000276	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	4.09e-05	0.000269	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	3.98e-05	0.000262	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—KRAS—colon cancer	3.96e-05	0.000261	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—AKT1—colon cancer	3.91e-05	0.000257	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—AKT1—colon cancer	3.91e-05	0.000257	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PPARG—colon cancer	3.85e-05	0.000253	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	3.66e-05	0.000241	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	3.66e-05	0.000241	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	3.58e-05	0.000236	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—AKT1—colon cancer	3.39e-05	0.000223	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	3.39e-05	0.000223	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—HRAS—colon cancer	3.37e-05	0.000222	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.25e-05	0.000214	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	3.11e-05	0.000205	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—AKT1—colon cancer	3.1e-05	0.000204	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—AKT1—colon cancer	3.04e-05	0.0002	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	3.01e-05	0.000198	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PPARG—colon cancer	2.99e-05	0.000197	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—AKT1—colon cancer	2.97e-05	0.000196	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—AKT1—colon cancer	2.92e-05	0.000192	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—AKT1—colon cancer	2.92e-05	0.000192	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	2.54e-05	0.000167	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTGS2—colon cancer	2.35e-05	0.000155	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—MYC—colon cancer	2.19e-05	0.000144	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.14e-05	0.000141	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—EP300—colon cancer	1.96e-05	0.000129	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—TYMS—colon cancer	1.69e-05	0.000111	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.69e-05	0.000111	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—AKT1—colon cancer	1.52e-05	0.0001	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CA—colon cancer	1.45e-05	9.53e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.4e-05	9.23e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ABCB1—colon cancer	1.37e-05	9.03e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—TYMS—colon cancer	1.35e-05	8.87e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PPARG—colon cancer	1.2e-05	7.87e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—AKT1—colon cancer	1.18e-05	7.78e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.04e-05	6.83e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PPARG—colon cancer	9.54e-06	6.28e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTGS2—colon cancer	9.4e-06	6.19e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—EP300—colon cancer	7.82e-06	5.15e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTGS2—colon cancer	7.51e-06	4.94e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—EP300—colon cancer	6.24e-06	4.11e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CA—colon cancer	5.79e-06	3.81e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—AKT1—colon cancer	4.73e-06	3.11e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CA—colon cancer	4.62e-06	3.04e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—AKT1—colon cancer	3.77e-06	2.48e-05	CbGpPWpGaD
